- Posts:
- 0 (0 per day)
- Karma:
- +0/-0
- Age:
- N/A
- Date Registered:
- April 29, 2024, 09:17:20 AM
- Local Time:
- May 16, 2024, 11:25:53 AM
- Last Active:
- April 29, 2024, 12:59:56 PM
Signature:
Your EZH2 inhibitor tazemetostat upregulates the actual appearance of CCL17/TARC within B-cell lymphoma and enhances T-cell employment.Cohort featu